The global market for Tissue Banking Equipment and Consumables was estimated at US$2.0 Billion in 2023 and is projected to reach US$4.3 Billion by 2030, growing at a CAGR of 11.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Global Tissue Banking Equipment and Consumables Market - Key Trends and Drivers Summarized
How Is Tissue Banking Equipment and Consumables Enabling Advances in Biomedical Research?
Tissue banking equipment and consumables are essential tools in biobanking, supporting the collection, processing, preservation, and storage of biological tissues for research and clinical use. The importance of biobanks has grown significantly in recent years, particularly with the rise of personalized medicine, regenerative therapies, and cancer research. Tissue samples preserved in biobanks are invaluable for understanding disease mechanisms, developing new treatments, and conducting clinical trials. The equipment used in tissue banking, such as cryopreservation units, freezers, and automated storage systems, ensures that tissues are stored under optimal conditions, while consumables like cryovials, reagents, and storage media are critical for maintaining tissue integrity during processing and storage.What Are the Key Segments Driving the Tissue Banking Equipment and Consumables Market?
Equipment includes cryopreservation units, automated storage systems, and sample tracking software. Consumables consist of items like cryovials, tubes, storage bags, and reagents used for processing and storing tissues. Applications range from oncology and regenerative medicine to drug discovery and clinical research. End-users of tissue banking equipment include hospitals, research laboratories, pharmaceutical companies, and academic institutions. The increasing demand for tissue samples in cancer research, personalized medicine, and stem cell therapies is driving the growth of this market across all these segments. Regionally, North America leads the market due to its well-established biobanking infrastructure and research capabilities, followed by Europe and Asia-Pacific.What Technological Advancements Are Driving the Tissue Banking Market?
The tissue banking industry has benefited from several technological advancements, particularly in automation and preservation technologies. Automated tissue processing systems are now enabling high-throughput workflows, reducing human error, and improving sample quality. Innovations in cryopreservation technologies, such as vitrification, are ensuring better preservation of cell viability and tissue structure. Digital systems, including cloud-based platforms and sample tracking software, are revolutionizing biobank management by enhancing data integrity, security, and accessibility. Additionally, advancements in sample labeling and tracking using RFID and barcoding technologies are helping to improve accuracy and compliance in tissue handling. These innovations are not only enhancing efficiency but also ensuring that biobanks can scale their operations to meet the growing demand for biological samples.What Factors Are Driving Growth in the Tissue Banking Equipment and Consumables Market?
The growth in the tissue banking equipment and consumables market is driven by several factors, including the rising demand for personalized medicine, advances in regenerative medicine, and the increasing use of tissue samples in cancer research. The expansion of biobanks and the growing emphasis on the quality and longevity of stored tissues are driving the need for advanced cryopreservation technologies and storage solutions. The rise of stem cell therapies and the need for high-quality tissue samples for drug discovery and clinical trials are also significant drivers. Additionally, the growing focus on automation, data security, and regulatory compliance in biobanking operations is fueling the adoption of sophisticated tissue banking equipment and consumables.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Tissue Banking Consumables segment, which is expected to reach US$2.5 Billion by 2030 with a CAGR of a 11.1%. The Tissue Banking Equipment segment is also set to grow at 12.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $532.9 Million in 2023, and China, forecasted to grow at an impressive 10.7% CAGR to reach $646.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Beckman Coulter, Inc., Biocision, LLC, BioKryo GmbH, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Questions Answered:
- How is the Global Tissue Banking Equipment and Consumables Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Tissue Banking Equipment and Consumables Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Tissue Banking Equipment and Consumables Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Select Competitors (Total 31 Featured):
- Beckman Coulter, Inc.
- Biocision, LLC
- BioKryo GmbH
- Biolife Solutions, Inc.
- Bluechiip Ltd.
- Brooks Automation, Inc.
- Chernobyl Tissue Bank
- Cureline, Inc.
- Custom Biogenic Systems, Inc.
- Eppendorf AG
- Hamilton Company
- IMA Pharma
- LifeLink Tissue Bank
- Merck KgaA
- PHC Europe B.V.
- Tata Memorial Hospital - Tissue Bank
- Tecan Group Ltd.
- The PXE International Blood and Tissue Bank
- Thermo Fisher Scientific, Inc.
- TuBaFrost Group
- Versiti
- VWR International LLC
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned
- Beckman Coulter, Inc.
- Biocision, LLC
- BioKryo GmbH
- Biolife Solutions, Inc.
- Bluechiip Ltd.
- Brooks Automation, Inc.
- Chernobyl Tissue Bank
- Cureline, Inc.
- Custom Biogenic Systems, Inc.
- Eppendorf AG
- Hamilton Company
- IMA Pharma
- LifeLink Tissue Bank
- Merck KgaA
- PHC Europe B.V.
- Tata Memorial Hospital - Tissue Bank
- Tecan Group Ltd.
- The PXE International Blood and Tissue Bank
- Thermo Fisher Scientific, Inc.
- TuBaFrost Group
- Versiti
- VWR International LLC
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 189 |
Published | December 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 2 Billion |
Forecasted Market Value ( USD | $ 4.3 Billion |
Compound Annual Growth Rate | 11.6% |
Regions Covered | Global |
No. of Companies Mentioned | 22 |